Meet the 2026 STARs: Aaron Whiteley, PhD
admin The Cancer Research Institute (CRI) has announced the prestigious STAR (Scientists Taking Risks) award for...
biotech
FDA Approves Lisraya (Brepocitinib) as First Oral Therapy for Rare Dermatomyositis, Marking a Milestone for Priovant Therapeutics
The U.S. Food and Drug Administration (FDA) has granted approval for brepocitinib, marketed as Lisraya,...
Biotech Sector Surges to Historic Peaks in August 2026, Fueled by Record IPOs and Robust M&A Activity Amidst Strategic Pipeline Refill Initiatives
The biotechnology sector is experiencing an unprecedented resurgence in August 2026, marked by the benchmark...
AstraZeneca, Ionis data spark debate about RNA drugs’ impact on deadly heart disease
Two years ago, Alnylam Pharmaceuticals unveiled groundbreaking study data, demonstrating that patients suffering from a...
Biopharma Dive’s Week in Review: FDA Vaccine Updates, Moderna’s Financial Gambit, Data Leak Fallout, and Critical Therapeutic Advancements
The biopharmaceutical sector witnessed a flurry of significant developments this past week, marked by crucial...
World Cancer Support Month Highlights the Indispensable ‘Village’ Behind Every Patient’s Journey to Survivorship.
As the global community observes World Cancer Support Month, attention is critically drawn not only...
Revolutionary Pancreatic Cancer Drug Rasonque Launched with $39,800 Monthly Price, Exceeding Expectations and Igniting Hope for Patients
The pharmaceutical landscape for metastatic pancreatic cancer has been fundamentally reshaped with the immediate launch...
Tezspire’s Success in Eosinophilic Esophagitis Trial Paves Way for Third Indication and Blockbuster Market Expansion
AstraZeneca and Amgen have announced a significant clinical triumph for their co-developed biologic, Tezspire (tezepelumab),...
Outer Bio Emerges from Stealth with Month-Long Living Skin Tissue and AI Platform, Revolutionizing Skincare and Therapeutic Discovery
Outer Bio, a pioneering startup operating at the nexus of biotechnology and artificial intelligence, has...
Personalized mRNA Cancer Vaccine and Checkpoint Inhibitor Combination Achieves Historic Phase 3 Success in High-Risk Melanoma
For decades, researchers have pursued an ambitious idea: What if a vaccine could teach a...
